The San Antonio Breast Cancer Symposium (SABCS) Annual meeting will be held virtually this year due to the ongoing COVID-19 pandemic and will highlight recent advances in the treatment and management of breast cancer.
View all videosSABCS 2020
⭐️Advances in both preclinical and clinical studies have demonstrated that metabolic interventions can dramatically enhance the efficacy of immune-based therapies for cancer @AACR #AACR21 https://twitter.com/viveksubbiah/status/1382723877210492928
🚨⭐️Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy @AACR #AACR21 https://cancerimmunolres.aacrjournals.org/content/9/3/255
A phase 2 trial presented by #AACR21 Brain #Metastasis session panelist Priscilla Brastianos @MGHCancerCenter showed that anti-PD-1 #immunotherapy was safe and associated with a 3 month OS of 60% in patients with leptomeningeal disease #breastcancer https://www.nature.com/articles/s41591-020-0918-0
🚨⭐️ “Combination Therapies for Precision Oncology: The Ultimate Whack-A-Mole Game” 👉🏼 Acknowledgements to our late Dr. Emil Freireich @MDAndersonNews Father of combination oncology clinical trials ! I know he is smiling from heaven. @AACR #AACR21
https://clincancerres.aacrjournals.org/content/early/2021/04/14/1078-0432.CCR-21-0254
#AACR21 Neoadjuvant Immunotherapy Session Panelist Tina Cascone @MDAndersonNews presented results from the NEOSTAR phase 2 clinical trial evaluating combo neoadjuvant #immunotherapy in patients with early stage #lungcancer #NSCLC Read more here! 👉https://www.nature.com/articles/s41591-020-01224-2
📣 @SerenaNikZainal of @Cambridge_Uni shares her highlights from #AACR21 👩⚕️🩺
Watch here 👉http://ow.ly/te7A50Epgjh👈
@VJOncology @AACR #Oncology #MedOnc #ClinOnc
SABCS 2020
The San Antonio Breast Cancer Symposium (SABCS) Annual meeting will be held virtually this year due to the ongoing COVID-19 pandemic and will highlight recent advances in the treatment and management of breast cancer.
View all videos⭐️Advances in both preclinical and clinical studies have demonstrated that metabolic interventions can dramatically enhance the efficacy of immune-based therapies for cancer @AACR #AACR21 https://twitter.com/viveksubbiah/status/1382723877210492928
🚨⭐️Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy @AACR #AACR21 https://cancerimmunolres.aacrjournals.org/content/9/3/255
A phase 2 trial presented by #AACR21 Brain #Metastasis session panelist Priscilla Brastianos @MGHCancerCenter showed that anti-PD-1 #immunotherapy was safe and associated with a 3 month OS of 60% in patients with leptomeningeal disease #breastcancer https://www.nature.com/articles/s41591-020-0918-0
🚨⭐️ “Combination Therapies for Precision Oncology: The Ultimate Whack-A-Mole Game” 👉🏼 Acknowledgements to our late Dr. Emil Freireich @MDAndersonNews Father of combination oncology clinical trials ! I know he is smiling from heaven. @AACR #AACR21
https://clincancerres.aacrjournals.org/content/early/2021/04/14/1078-0432.CCR-21-0254
#AACR21 Neoadjuvant Immunotherapy Session Panelist Tina Cascone @MDAndersonNews presented results from the NEOSTAR phase 2 clinical trial evaluating combo neoadjuvant #immunotherapy in patients with early stage #lungcancer #NSCLC Read more here! 👉https://www.nature.com/articles/s41591-020-01224-2
📣 @SerenaNikZainal of @Cambridge_Uni shares her highlights from #AACR21 👩⚕️🩺
Watch here 👉http://ow.ly/te7A50Epgjh👈
@VJOncology @AACR #Oncology #MedOnc #ClinOnc
